Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in …

Objective Coagulation and inflammatory parameters are mildly altered in children with
SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and …

Background Multiple investigators have described an increased incidence of
thromboembolic events in SARS‐CoV‐2–infected individuals. Data concerning hemostatic …

Most children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
have mild or minimal disease, with a small proportion developing severe disease or …

We report the clinical and laboratory coagulation characteristics of 27 pediatric and young
adult patients (2 months to 21 years) treated for symptomatic COVID‐19 at a children's …

To the Editor: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is often associated with hypercoagulability …

Background Observational studies indicate that children hospitalized with COVID‐19‐
related illness, like adults, are at increased risk for venous thromboembolism (VTE). A …

Since the initial description in 2019, the novel coronavirus SARS-Cov-2 infection (COVID-
19) pandemic has swept the globe. The most severe form of the disease presents with fever …

COVID-19 is associated with a variety of clinical complications including coagulopathy,
which frequently results in venous thromboembolism (VTE). Retrospective analyses …

In October 2019, a viral infectious disease appeared in the city of Wuhan in China. A new
betacoronavirus, SARS-CoV-2, has been recognized as the responsible pathogen in this …